
Healthcare · NSE / BSE
Incorporated in 2010, Nephrocare Health Services Ltd. provides comprehensive dialysis care through an extensive network of clinics across India and select international markets. As of March 31, 2025, the company operated 490 clinics—447 in India and 43 across the Philippines, Uzbekistan, and Nepal—including the world’s largest dialysis clinic in Uzbekistan. Nephrocare serves 269 cities across 21 states and 4 union territories, with nearly 77% of its centers located in tier II and III regions to improve access for underserved populations. In FY 2025, it treated 29,281 patients and delivered over 2.88 million dialysis sessions, representing about 10% of India’s dialysis patient base. The company managed 5,068 dialysis machines by March 2025, demonstrating consistent growth over prior years. Nephrocare has also partnered with leading hospital chains such as Max, Fortis Escorts, Care Hospitals, Wockhardt, Paras, CMRI, Jehangir Hospital, and Ruby Hall Clinic to operate in-house dialysis centers and enhance service reach.
Price Band
₹438 – ₹460
Issue Size
₹871 Cr
Lot Size
32 shares
GMP
+7.8%
Est. Listing
₹496
at current GMP
Subscribed
14.08x
overall
Open
10 Dec 2025
Close
12 Dec 2025
Allotment
15 Dec 2025
Refund
16 Dec 2025
Demat Credit
17 Dec 2025
Listing
17 Dec 2025